申请人:Pharmacia & Upjohn Company
公开号:US05847153A1
公开(公告)日:1998-12-08
The present invention provides a compound of formula I ##STR1## or pharmaceutical acceptable salts thereof wherein R.sub.1 is C.sub.4-12 alkyl, C.sub.4-12 alkenyl, C.sub.4-12 alkynyl, --(CH.sub.2).sub.h -C.sub.3-8 cycloalkyl, --(CH.sub.2).sub.h -aryl, or --(CH.sub.2).sub.h -het; R.sub.2 is C.sub.1-12 alkyl, C.sub.2-12 alkenyl, C.sub.2-12 alkynyl, --(CH.sub.2).sub.h -C.sub.3-8 cycloalkyl, --(CH.sub.2).sub.h -C.sub.3-8 cycloalkenyl, --(CH.sub.2).sub.h -aryl, --(CH.sub.2).sub.h -het, --(CH.sub.2).sub.h -Q, --(CH.sub.2).sub.i -X-R.sub.4, or --(CH.sub.2).sub.i CHR.sub.5 R.sub.6. The compounds are inhibitors of matrix metalloproteinases involved in tissue degradation.
本发明提供了一种具有以下结构的化合物I ##STR1## 或其药用盐,其中R.sub.1为C.sub.4-12烷基,C.sub.4-12烯基,C.sub.4-12炔基,--(CH.sub.2).sub.h -C.sub.3-8环烷基,--(CH.sub.2).sub.h -芳基,或--(CH.sub.2).sub.h -杂环基;R.sub.2为C.sub.1-12烷基,C.sub.2-12烯基,C.sub.2-12炔基,--(CH.sub.2).sub.h -C.sub.3-8环烷基,--(CH.sub.2).sub.h -C.sub.3-8环烯基,--(CH.sub.2).sub.h -芳基,--(CH.sub.2).sub.h -杂环基,--(CH.sub.2).sub.h -Q,--(CH.sub.2).sub.i -X-R.sub.4,或--(CH.sub.2).sub.i CHR.sub.5 R.sub.6。这些化合物是涉及组织降解的基质金属蛋白酶抑制剂。